Cover Image
市場調查報告書

口腔潰瘍治療藥的全球市場 (2015∼2019年)

Global Mouth Ulcer Treatment Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 338873
出版日期 內容資訊 英文 62 Pages
訂單完成後即時交付
價格
Back to Top
口腔潰瘍治療藥的全球市場 (2015∼2019年) Global Mouth Ulcer Treatment Market 2015-2019
出版日期: 2015年09月02日 內容資訊: 英文 62 Pages
簡介

所謂口腔潰瘍,是在口腔內的粘膜上產生的潰瘍。不是特別重大的疾病,不會危害人體。經由口腔內的損傷,或是由於其他的基礎疾病發源。主要的原因有緊張狀態和外傷,感染疾病,過敏,遺傳的趨勢,營養上的偏傾等通常,10∼14天自然地治癒,不過,要是仍殘留症狀時,便必須治療。可選擇抗菌劑、麻醉劑、皮質類固醇、止痛藥、抗組織胺藥物等各種治療。全球口腔潰瘍治療藥的市場2014∼2019年預計以4.18%的年複合成長率(CAGR) 成長。

本報告提供全球口腔潰瘍的治療藥市場相關分析、疾病概要和基本的市場結構、市場規模趨勢 (今後5年的預測值)、各劑型、各類藥物、各地區的詳細趨勢、推動、阻礙市場要素與其影響力、主要企業簡介、今後的市場機會等調查評估。

第1章 摘要整理

  • 分析結果的概要

第2章 分析範圍

  • 分析概要
  • 大供應商的主要產品

第3章 市場分析技術

  • 分析方法
  • 經濟指標

第4章 簡介

  • 市場趨勢的概要

第5章 口腔潰瘍:概要

  • 口腔潰瘍的種類
  • 病理生理學
  • 原因
  • 各種診斷方法
  • 疾病管理法
  • 流行病學

第6章 市場環境

  • 市場概要
  • 市場規模與其預測
  • 波特的五力分析

第7章 各劑型的市場區隔

  • 凝膠
  • 噴霧
  • 漱藥
  • 錠劑

第8章 各藥物類別的市場區隔

  • 抗菌物質
  • 麻醉劑
  • 皮質類固醇
  • 止痛藥
  • 抗組織胺藥物

第9章 地區區分

第10章 市場成長的推動要素

第11章 推動因素與其影響力

第12章 市場課題

第13章 推動因素、課題的影響力

第14章 市場趨勢

第15章 供應商環境

  • 競爭方案
  • 市場佔有率分析
  • 其他卓越供應商

第16章 主要供應商分析

  • 3M Company
  • Blistex
  • Church & Dwight
  • Taro Pharmaceuticals
  • Valeant Pharmaceuticals

第17章 附錄

  • 簡稱集

第18章 關於Technavio

圖表一覽

目錄
Product Code: IRTNTR7108

About mouth ulcers

Mouth ulcers are sores that form in the mucous membranes of the oral cavity. They are noncritical and do not pose a health hazard. Mouth ulcers can be caused by oral injury or may arise as a result of underlying disease. They can be associated with intense or moderate pain. The etiology of mouth ulcers include stress, injury, infection, allergy, genetic tendency, and nutritional deficiencies. Treatment involves identification of the cause. The ulcers normally heal by themselves in 10-14 days. Medical treatment is required if the condition persists. Various treatment options, such as antimicrobials, anesthetics, corticosteroids, analgesics, and antihistamines are used to treat them.

Technavio's analysts forecast the global mouth ulcer treatment market to grow at a CAGR of 4.18% over the period 2014-2019.

Covered in this report

The report covers the present scenario and growth prospects of the global mouth ulcer treatment market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various pharmaceutical products used in the treatment of mouth ulcers.

Technavio's report, Global Mouth Ulcer Treatment Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global mouth ulcer treatment market and its growth prospects in the coming years. The report includes a discussion on the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • 3M Healthcare
  • Blistex
  • Church & Dwight
  • Taro Pharmaceuticals
  • Valeant Pharmaceuticals

Other Prominent Vendors

  • Blairex Laboratories
  • Bristol-Myers Squibb
  • Colgate-Palmolive
  • Diomed
  • Dr.Reddy's
  • EPIEN Medical
  • Focus Pharmaceuticals
  • GlaxoSmithKline
  • Henry Schein
  • Macoven Pharmaceuticals
  • Meda pharmaceuticals
  • Novartis
  • Pfizer
  • Sinclair IS Pharma
  • Svizera Labs
  • Zila Pharmaceuticals

Market driver

  • Increase in prevalence of mouth ulcers
  • For a full, detailed list, view our report

Market challenge

  • Low diagnosis rates
  • For a full, detailed list, view our report

Market trend

  • Focus on emerging markets
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Mouth ulcers: Overview

  • Types of mouth ulcers
  • Pathophysiology
  • Causes
  • Differential diagnosis
  • Management
  • Epidemiology

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by formulation

  • Gel
  • Spray
  • Mouthwash
  • Lozenges

PART 08: Market segmentation by drug class

  • Antimicrobial
  • Anesthetic
  • Corticosteroid
  • Analgesic
  • Antihistamine

PART 09: Geographical segmentation

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 16: Key vendor analysis

  • 3M Company
  • Blistex
  • Church & Dwight
  • Taro Pharmaceuticals
  • Valeant Pharmaceuticals

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Clinical features of different types of ulcers
  • Exhibit 03: Causes of mouth ulcers
  • Exhibit 04: Differential diagnosis of mouth ulcers
  • Exhibit 05: Medication for the management of mouth ulcers
  • Exhibit 06: Treatment algorithm for mouth ulcers
  • Exhibit 07: Global mouth ulcer treatment market 2014-2019 ($ billions)
  • Exhibit 08: Five forces analysis
  • Exhibit 09: Global mouth ulcer treatment market segment by formulation
  • Exhibit 10: Global mouth ulcer treatment market segment by drug class
  • Exhibit 11: Frequently used topical corticosteroids
  • Exhibit 12: Percentage share of drug classes for mouth ulcer treatment
  • Exhibit 13: Segmentation of global mouth ulcer treatment market by geography 2014
  • Exhibit 14: Impact of drivers
  • Exhibit 15: Impact of drivers and challenges
  • Exhibit 16: Comparison of aging population in APAC 2010 and 2050 ($ millions)
  • Exhibit 17: YoY growth and revenue generated from healthcare segment 2011-2014 ($ billions)
  • Exhibit 18: Share of revenue by different segments 2014
  • Exhibit 19: YoY growth and revenue generated from personal care products 2012-2014 ($ millions)
  • Exhibit 20: Share of revenue by different segments 2014
  • Exhibit 21: Blistex: Product segmentation
Back to Top